de Jaegere P P, Eefting F D, Stella P R, Meijburg H W, Westerhof P W, Robles de Medina E
Division of Cardiology, Heart Lung Institute, University Hospital Utrecht, the Netherlands.
Ann Thorac Surg. 1997 Jun;63(6 Suppl):S23-7. doi: 10.1016/s0003-4975(97)00438-4.
In the majority of patients with chronic coronary artery disease, treatment is aimed at palliation or prolongation of disease-free intervals and consists of either pharmacologic therapy or coronary revascularization. As a result of continuous refinements and improvements in both surgical and catheter-based revascularization techniques, modalities, and adjunctive pharmacologic therapy, an increasing number of patients may benefit from coronary revascularization. This also engenders difficult choices for the physicians responsible for selecting the most appropriate treatment. To achieve and provide optimal patient care an open and principled discussion with all parties involved is mandatory and must be based on the integration of clinical experience and data from both basic and clinical research. The purpose of this article is to provide the interventional cardiologist's view on the treatment of patients with atherosclerotic coronary artery disease.
在大多数慢性冠状动脉疾病患者中,治疗旨在缓解症状或延长无病间期,包括药物治疗或冠状动脉血运重建。由于外科手术和基于导管的血运重建技术、方式及辅助药物治疗不断改进和完善,越来越多的患者可能从冠状动脉血运重建中获益。这也给负责选择最合适治疗方法的医生带来了艰难抉择。为实现并提供最佳的患者护理,必须与所有相关方进行开放且有原则的讨论,且这种讨论必须基于临床经验以及基础研究和临床研究的数据整合。本文旨在提供介入心脏病学家对动脉粥样硬化性冠状动脉疾病患者治疗的观点。